HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

Lauder Innovates To Convert Consumers From Mass To Prestige

This article was originally published in The Rose Sheet

  • News
  • The Rose Sheet

Executive Summary

The Estee Lauder Companies is relying on increased promotional activity and in-store service to lure consumers from mass to prestige product counters

You may also be interested in...



CEW Awards Most Innovative Products in Beauty

The Cosmetic Executive Women celebrated some of the most innovative products in beauty at its 17th annual awards ceremony, known as the Beauty “Oscars,” for its star-studded appeal.

CEW Awards Most Innovative Products in Beauty

The Cosmetic Executive Women celebrated some of the most innovative products in beauty at its 17th annual awards ceremony, known as the Beauty “Oscars,” for its star-studded appeal.

Marketing In Brief

Estee Lauder Licenses Natural Ingredients

Table

View full table

Related Content

HBW Insight
HBW Insight
Tags:
Latest Headlines

US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising

MoCRA’s Adulteration Ambiguity And FDA’s New Cosmetic Recall Authority: Attorney Weighs In

Cosmetic And Personal Care Trademark Review: 16 April

Health And Wellness Weekly Trademarks Review: 16 April

See All
UsernamePublicRestriction

Register

RS017131

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By